Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Five-second countdowns for throw-ins and goal kicks are set to feature at this summer's FIFA World Cup as football's lawmakers prepare to introduce a raft of measures to speed up play. The success of ...

CPR Classical's annual Carol Countdown® has been crowning Colorado's favorite carol for the past 17 years! Read about exciting carol matchups, enter to win tickets to seasonal holiday events, and vote ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...